BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37711421)

  • 1. Reductions in anxiety and depression symptoms in a subset of outpatients with problematic substance use who received ketamine-assisted psychotherapy: a two-year retrospective chart review.
    Whinkin E; Eparwa TRJ; Julseth MC; Schneider A; Aggarwal SK
    Front Psychiatry; 2023; 14():1160442. PubMed ID: 37711421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case series of group-based ketamine-assisted psychotherapy for patients in residential treatment for eating disorders with comorbid depression and anxiety disorders.
    Robison R; Lafrance A; Brendle M; Smith M; Moore C; Ahuja S; Richards S; Hawkins N; Strahan E
    J Eat Disord; 2022 May; 10(1):65. PubMed ID: 35524316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketamine-Assisted Group Psychotherapy for Frontline Healthcare Workers with COVID-19-Related Burnout and PTSD: A Case Series of Effectiveness/Safety for 10 Participants.
    Robison R; Brendle M; Moore C; Cross H; Helm L; Darling S; Thayer S; Thielking P; Shannon S
    J Psychoactive Drugs; 2024; 56(1):23-32. PubMed ID: 36862829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating Clinical Outcomes in Patients Being Treated Exclusively via Telepsychiatry: Retrospective Data Analysis.
    Person C; O'Connor N; Koehler L; Venkatachalam K; Gaveras G
    JMIR Form Res; 2023 Dec; 7():e53293. PubMed ID: 37991899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Component analysis of a synchronous and asynchronous blended care CBT intervention for symptoms of depression and anxiety: Pragmatic retrospective study.
    Lungu A; Wickham RE; Chen SY; Jun JJ; Leykin Y; Chen CE
    Internet Interv; 2022 Apr; 28():100536. PubMed ID: 35433277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. At-home, sublingual ketamine telehealth is a safe and effective treatment for moderate to severe anxiety and depression: Findings from a large, prospective, open-label effectiveness trial.
    Hull TD; Malgaroli M; Gazzaley A; Akiki TJ; Madan A; Vando L; Arden K; Swain J; Klotz M; Paleos C
    J Affect Disord; 2022 Oct; 314():59-67. PubMed ID: 35809678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of a Digital Mental Health Program on Anxiety and Depression Symptoms: Retrospective Analysis of Clinical Severity.
    Dzubur E; Yu J; Hoffman J; Painter S; James R; Shah B
    JMIR Form Res; 2023 Oct; 7():e36596. PubMed ID: 37788069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of brief screening measures for depression and anxiety in young people with substance use disorders.
    Bentley KH; Sakurai H; Lowman KL; Rines-Toth L; McKowen J; Pedrelli P; Evins AE; Yule AM
    J Affect Disord; 2021 Mar; 282():1021-1029. PubMed ID: 33601674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of in-person vs. telebehavioral health outcomes from rural populations across America.
    McCord C; Ullrich F; Merchant KAS; Bhagianadh D; Carter KD; Nelson E; Marcin JP; Law KB; Neufeld J; Giovanetti A; Ward MM
    BMC Psychiatry; 2022 Dec; 22(1):778. PubMed ID: 36496352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-world depression, anxiety and safety outcomes of intramuscular ketamine treatment: a retrospective descriptive cohort study.
    Ahuja S; Brendle M; Smart L; Moore C; Thielking P; Robison R
    BMC Psychiatry; 2022 Oct; 22(1):634. PubMed ID: 36192794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical characteristics and related factors of somatization symptoms in outpatients with psychiatric disorders of the department of cardiology in general hospitals].
    Zhang YN; Jin C; Ning L; Gong S; Xiao Y; Yu GL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):907-912. PubMed ID: 31744281
    [No Abstract]   [Full Text] [Related]  

  • 12. Self-Directed Engagement with a Mobile App (Sinasprite) and Its Effects on Confidence in Coping Skills, Depression, and Anxiety: Retrospective Longitudinal Study.
    Silva Almodovar A; Surve S; Axon DR; Cooper D; Nahata MC
    JMIR Mhealth Uhealth; 2018 Mar; 6(3):e64. PubMed ID: 29549066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case report: Medical student types journals during ketamine infusions for suicidal ideation, treatment-resistant depression, post-traumatic stress disorder, and generalized anxiety disorder.
    Willms J; McCauley B; Kerr L; Presto P; Arun A; Shah N; Irby K; Strawn M; Kopel J
    Front Psychiatry; 2022; 13():1020214. PubMed ID: 36620675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Problematic Smartphone Use and Mental Health in Chinese Adults: A Population-Based Study.
    Guo N; Luk TT; Ho SY; Lee JJ; Shen C; Oliffe J; Chan SS; Lam TH; Wang MP
    Int J Environ Res Public Health; 2020 Jan; 17(3):. PubMed ID: 32013111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Effectiveness of Intravenous Racemic Ketamine Infusions in a Large Community Sample of Patients With Treatment-Resistant Depression, Suicidal Ideation, and Generalized Anxiety Symptoms: A Retrospective Chart Review.
    Oliver PA; Snyder AD; Feinn R; Malov S; McDiarmid G; Arias AJ
    J Clin Psychiatry; 2022 Sep; 83(6):. PubMed ID: 36112599
    [No Abstract]   [Full Text] [Related]  

  • 16. Psychosocial and Functional Predictors of Depression and Anxiety Symptoms in Veterans and Service Members With TBI: A VA TBI Model Systems Study.
    Benavides AM; Finn JA; Tang X; Ropacki S; Brown RM; Smith AN; Stevens LF; Rabinowitz AR; Juengst SB; Johnson-Greene D; Hart T
    J Head Trauma Rehabil; 2021 Nov-Dec 01; 36(6):397-407. PubMed ID: 33656470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the Patient Health Questionnaire-9 and the Generalized Anxiety Disorder-7 in Lithuanian individuals with anxiety and mood disorders.
    Stanyte A; Fineberg NA; Podlipskyte A; Gecaite-Stonciene J; Macijauskiene J; Steibliene V; Burkauskas J
    J Psychiatr Res; 2023 Aug; 164():221-228. PubMed ID: 37385000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active mechanisms of ketamine-assisted psychotherapy: A systematic review.
    Joneborg I; Lee Y; Di Vincenzo JD; Ceban F; Meshkat S; Lui LMW; Fancy F; Rosenblat JD; McIntyre RS
    J Affect Disord; 2022 Oct; 315():105-112. PubMed ID: 35905796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Cohort-Based Case Report: The Impact of Ketamine-Assisted Therapy Embedded in a Community of Practice Framework for Healthcare Providers With PTSD and Depression.
    Dames S; Kryskow P; Watler C
    Front Psychiatry; 2021; 12():803279. PubMed ID: 35095617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Outcomes of a Therapist-Supported, Smartphone-Based Intervention for Elevated Symptoms of Depression and Anxiety: Quasiexperimental, Pre-Postintervention Study.
    Economides M; Ranta K; Nazander A; Hilgert O; Goldin PR; Raevuori A; Forman-Hoffman V
    JMIR Mhealth Uhealth; 2019 Aug; 7(8):e14284. PubMed ID: 31452521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.